A similar phenomenon has been observed in diffuse large B-cell lymphoma that lacks MCT4 expression, and the simultaneous targeting of glycolysis and oxidative phosphorylation by the combination of AZD3965 and IACS-010759, an inhibitor of mitochondrial complex I, was recently reported to be more effective30. Here, SLC16A4 is linked to diffuse large B-cell lymphoma.